Approval · Notice of Compliance 1679 · 2001
ETHYOL: Notice of Compliance 1679
Issued May 8, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1679
- Date
- May 8, 2001
- Company
- Medimmune Oncology, Inc.Gaithersburg, Maryland, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: to reduce the incidence and severity of radiation-induced xerostomia, in patients with squamous cell carcinoma of the head and neck
- Therapeutic class
- Cytoprotectrive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETHYOL | Not yet assigned | — |
Medicinal ingredients
- AMIFOSTINE 500 MG per VIAL